Cohen Shlomo
Ben-Gurion University of the Negev.
Bioethics. 2014 Mar;28(3):147-54. doi: 10.1111/j.1467-8519.2012.01983.x. Epub 2012 Jul 5.
The nocebo effect, the mirror-phenomenon to the placebo effect, is when the expectation of a negative outcome precipitates the corresponding symptom or leads to its exacerbation. One of the basic ethical duties in health care is to obtain informed consent from patients before treatment; however, the disclosure of information regarding potential complications or side effects that this involves may precipitate a nocebo effect. While dilemmas between the principles of respect for patient autonomy and of nonmaleficence are recognized in medical ethics, there has not yet been an ethical discussion focused on the potential dilemma raised by the nocebo effect of informed consent (NEIC). This dilemma is especially pernicious, since it involves a direct causality of harm by the caregiver that is unparalleled by other potential harmful effects of information disclosure. This paper articulates the dilemma of the NEIC and offers a seminal ethical analysis.
反安慰剂效应是安慰剂效应的镜像现象,指对负面结果的预期会引发相应症状或使其加重。医疗保健中的一项基本道德义务是在治疗前获得患者的知情同意;然而,披露这其中涉及的潜在并发症或副作用信息可能会引发反安慰剂效应。虽然在医学伦理中承认尊重患者自主权和不伤害原则之间存在困境,但尚未有针对知情同意反安慰剂效应(NEIC)引发的潜在困境展开的伦理讨论。这种困境尤其有害,因为它涉及到护理人员造成伤害的直接因果关系,这是信息披露的其他潜在有害影响所无法比拟的。本文阐述了NEIC的困境并提供了开创性的伦理分析。